2d
Zacks Investment Research on MSNTwist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?Twist Bioscience (TWST) shares rallied 6.6% in the last trading session to close at $39.13. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Victory Capital Management Inc. boosted its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 12.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "We constantly look for ways to meet the academic research community in their place of need. By making Express shipping the default option at ...
We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...
Twist Bioscience Co. has a twelve month low of $27.41 and a twelve month high of $60.90. The company has a quick ratio of 4.62, a current ratio of 4.96 and a debt-to-equity ratio of 0.03.
Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate ...
TD Cowen analyst Brendan Smith maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $58.00. The ...
SOUTH SAN FRANCISCO, Calif., February 03, 2025--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, ...
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results